Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
ABSTRACT MiR‐21‐5p is an anti‐apoptotic miRNA known to mediate the protective effect of mesenchymal stromal cell‐secreted exosomes (MSC‐Exo) against oxidative stress‐induced cell death. In the present research we employed murine lung ischemia/reperfusion (I/R) model and in vitro hypoxia/reoxygenation (H/R) model using primary murine pulmonary endothelial cells to investigate whether MSC‐Exo could alleviate lung IRI by transporting miR‐21‐5p. Our data suggested that intratracheal administration of MSC‐Exo or miR‐21‐5p agomir significantly reduced lung edema and dysfunction, M1 polarization of alveolar macrophages as well as secretion of HMGB1, IL‐8, IL‐1&bgr;, IL‐6, IL‐17 and TNF‐&agr;. Pre‐challenge of MSCs by H/R significant increased miR‐21‐5p expression level in exosomes they secreted and the anti‐IRI effect of these MSC‐Exo, while pre‐treatment of MSCs with miR‐21‐5p antagomir showed opposite effect. We further demonstrated that MSC‐Exo ameliorated IRI in vivo or H/R induced apoptosis in vitro by inhibiting both intrinsic and extrinsic apoptosis pathway via miR‐21‐5p targeting PTEN and PDCD4, while artificial overexpressing PTEN or PDCD4 significantly attenuated the anti‐apoptotic effect of MSC‐Exo in vitro. Treatment with miR‐21‐5p agomir mimicked the IRI‐reducing and anti‐apoptotic effect of MSC‐Exo. Our data suggested that MSC‐Exo alleviate IRI in lung in an exosomal miR‐21‐5p‐dependent manner. Treatment with MSC‐Exo or miR‐21‐5p agomir might ameliorate IRI in lung.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215
Morrison, T. J., Jackson, M. V., Cunningham, E. K., Kissenpfennig, A., McAuley, D. F., O’Kane, C. M., & Krasnodembskaya, A. D. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0170oc · Cited by 796 · cited 1×
“Other studies also pointed that MSC-Exo can skew macrophage polarization to the M2 phenotype in different lung injury models (Morrison et al., 2017; Willis et al., 2018).”
Das, A., Ganesh, K., Khanna, S., Sen, C. K., & Roy, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300613 · Cited by 320 · cited 1×
“Notably, miR-21-5p has been suggested to reduce pulmonary cell apoptosis and lung injury by targeting the proapoptotic genes such as PTEN and PDCD4, the functions of which have already been linked to the development of lung injury (Das et al., 2014; Elmadbouh and Ashraf, 2017; White et al., 2014; Zhou et al., 2015; Zh…”
Cited by
Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8121605 · Cited by 795
“I/R-induced lung injury BM MSC-Exos lung epithelial cells suppression of caspase-3,-8 and -9 Inhibition of apoptosis; alleviation of lung injury [50]”
BackgroundInfluentialXiao, K., He, W., Guan, W., Hou, F., Yan, P., Xu, J., Zhou, T., Liu, Y., & Xie, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03034-3 · Cited by 233
Mesenchymal stem cell immunomodulation: in pursuit of controlling COVID-19 related cytokine storm
Song, N., Wakimoto, H., Rossignoli, F., Bhere, D., Ciccocioppo, R., Chen, K.-S., Khalsa, J. K., Mastrolia, I., Samarelli, A. V., Dominici, M., et al. (2021) · Stem Cells · doi:10.1002/stem.3354 · Cited by 62
Wang, B., Yu, P., Lin, W., & Zhai, Z. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/5543212 · Cited by 5
Metadata
- Authors
- Li, J. W., Wei, L., Han, Z., & Chen, Z.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 852
- Pages
- 68-76
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2911269611
- Cited by
- 208
- References
- 3
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.